top of page

Latest News

A close-up of an open hand holding multiple HIV medication pills of different shapes, sizes, and colors.

A close-up of an open hand holding multiple HIV medication pills of different shapes, sizes, and colors.

A New Single-Tablet Option for HIV's "Forgotten Population" Could Change Lives. Will Policy Let It?

New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?

Mar 309 min read

Side-by-side photos of Senator Elizabeth Warren and Senator Josh Hawley, both speaking and gesturing during public appearances.

Side-by-side photos of Senator Elizabeth Warren and Senator Josh Hawley, both speaking and gesturing during public appearances.

Warren and Hawley Want to Break Up Big Medicine

Break Up Big Medicine Act would force structural separation of insurers, PBMs, and pharmacies.

Feb 228 min read

President Trump speaks at a podium in the Roosevelt Room of the White House, surrounded by four senior health officials in suits. To the right, a large poster titled "Biden's Bad Drug Price Deal" displays a bar chart comparing U.S. prescription drug prices to those in other countries, showing significantly higher costs for Americans.

President Trump speaks at a podium in the Roosevelt Room of the White House, surrounded by four senior health officials in suits. To the right, a large poster titled "Biden's Bad Drug Price Deal" displays a bar chart comparing U.S. prescription drug prices to those in other countries, showing significantly higher costs for Americans.

Third Wave of Medicare Drug Price Negotiation Adds More Potential Peril

Medicare drug negotiation's third wave includes Biktarvy, raising HIV treatment access concerns.

Feb 155 min read

A middle-aged man stands at a pharmacy pickup counter holding a prescription receipt, looking down at it with a concerned expression. The pharmacy background is slightly out of focus, with pill bottles and a register window visible. The image has a muted, documentary-style tone with natural overhead lighting.

A middle-aged man stands at a pharmacy pickup counter holding a prescription receipt, looking down at it with a concerned expression. The pharmacy background is slightly out of focus, with pill bottles and a register window visible. The image has a muted, documentary-style tone with natural overhead lighting.

Equipping Patients with Tools to Reclaim the Promise of 340B

340B program drifted from patient benefit; federal reform needed for transparency and accountability.

Jan 184 min read

340B - Are Patients at the Table or on the Menu? Reflections on the HELP Committee Hearing on 340B

Senate HELP Committee hearing reveals how 340B drug program expansion reflects hospital business strategy rather than patient benefit.

Nov 2, 20254 min read

CBO Data Proves Hospital Systems Exploit 340B Drug Program for Billions

Congressional Budget Office confirms 340B program expansion driven by hospital exploitation rather than pharmaceutical price inflation.

Sep 14, 20256 min read

Most Favored Nation, Least Favored Patients

Most Favored Nation pricing threatens to import restrictive QALY-based frameworks that discriminate against expensive treatments.

Aug 24, 20257 min read

HRSA Tightens STI Clinic 340B Rules Amid Industry Lawsuit

HRSA clarifies 340B eligibility for STI clinics while manufacturers challenge Ryan White program participation.

Aug 17, 20255 min read

HRSA's 340B Pilot Tests What Already Works While Ignoring What Doesn't

HRSA's 340B pilot program replicates existing successful models rather than addressing structural program exploitation.

Aug 10, 20255 min read

Medicaid loses billions as 340B program expansion collides with state budgets

340B program expansion drains billions from state Medicaid budgets while failing to deliver promised drug cost savings.

Jul 20, 20256 min read

CMS Draft Guidance Creates Regulatory Vacuum in 340B Drug Pricing

CMS draft guidance on 340B claims modifiers creates ambiguity and enforcement gaps threatening program integrity and beneficiary access.

Jun 1, 20257 min read

The High Cost of Middlemen Medicine

Pharmacy benefit managers extract billions while adding no value, increasing costs without improving patient access or health outcomes.

May 11, 20256 min read

Mixed Signals - Trump's Drug Policy Undermines Its Own Goals

Trump administration's contradictory drug pricing policies undermine goals of affordability and innovation incentives.

Apr 13, 20255 min read

PDAB Chicanery - How Drug Affordability Boards Are Undermining Public Engagement

State Prescription Drug Affordability Boards limit public input while basing pricing decisions on flawed methodologies.

Mar 30, 20256 min read

FTC Exposes PBM Price Gouging of Specialty Generic Drugs

FTC investigation confirms pharmacy benefit managers extracted billions in excess revenue through specialty drug markup schemes.

Jan 26, 20257 min read

Biden's Inaction Leaves Copay Assistance in Limbo

Federal policy failures on copay accumulator programs restrict patient assistance benefits.

Oct 13, 20247 min read

FTC Sues Major PBMs for Unfair Practices Affecting Drug Costs

FTC complaint against major PBMs for anticompetitive rebating and insulin pricing.

Oct 6, 20248 min read

Prescription Drug Affordability Boards - A Threat to Ending the HIV Epidemic

Potential harms of state PDABs on HIV treatment access and ending the epidemic.

Jun 30, 20248 min read

How the IRA's Price Controls Could Backfire on Patients

Unintended consequences of Inflation Reduction Act drug pricing provisions.

Jun 23, 20247 min read

Eye on 2024 - Federal Action on PBMs, 340B, and Telehealth

2024 federal healthcare policy priorities: 340B reform, PBM oversight, and telehealth.

Jan 7, 20244 min read

We Need Your Support Today!

bottom of page